Centessa Pharmaceuticals plc (CNTA) Tops Q1 EPS by 16c

Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q1 EPS of ($0.20), $0.16 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $15 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.

You May Also Be Interested In

• Northland Upgrades Evolution Petroleum (EPM) to Outperform 'on Pullback & Attractive Royalty Acquisition'
• William Blair Starts Terawulf Inc. (WULF) at Outperform
• H.C. Wainwright Reiterates Buy Rating on Roivant Sciences (ROIV)